Back
Protara Therapeutics 10K Form
Buy
57
TARA
Protara Therapeutics
Last Price:
2.60
Seasonality Move:
31.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TARA News And Ratings
See the #1 stock for the next 7 days that we like better than TARA
TARA Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-7.74M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.46 |
Price / Book: | 0.58 |
Profitability
EPS (TTM): | -3.19000 |
---|---|
Net Income (TTM): | $-40.69M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Protara Therapeutics Earnings Forecast
Key Protara Therapeutics Financial Ratios
- The Interest Expense is -1.72% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Protara Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | TARA |
CUSIP: | 74365U |
Website: | protaratx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
TARA Technical Analysis vs Fundamental Analysis
Buy
57
Protara Therapeutics (TARA)
is a Buy
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a Buy
The current Protara Therapeutics [TARA] share price is $2.58. The Score for TARA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.